Nat Med |Indlela ye-multi-omics yokwenza imephu ye-tumor edibeneyo

Nat Med |Indlela ye-multi-omics yokwenza imephu ye-tumor edibeneyo, i-immune kunye ne-microbial landscape yomhlaza we-colorectal ibonisa intsebenziswano ye-microbiome kunye ne-immune system.
Nangona iimpawu zebhayoloji zomhlaza wekolon yokuqala ziye zafundwa ngokubanzi kwiminyaka yakutshanje, izikhokelo zeklinikhi zangoku zixhomekeke kuphela kwi-tumor-lymph node-metastasis staging kunye nokufumanisa iziphene ze-DNA zokulungisa (MMR) okanye ukungazinzi kwe-microsatellite (MSI) (ukongeza kuvavanyo oluqhelekileyo lwe-pathology. ) ukumisela iingcebiso zonyango.Abaphandi baye baqaphela ukunqongophala konxulumano phakathi kweempendulo zemfuza ezisekelwe kwi-immune, iiprofayili ze-microbial, kunye ne-tumor stroma kwi-Cancer Genome Atlas (TCGA) ye-colorectal cancer cohort kunye nokusinda kwesigulana.

Njengoko uphando luqhubela phambili, iimpawu zobungakanani bomhlaza we-colorectal osisiseko, kubandakanya iseli yomhlaza, i-immune, i-stromal, okanye i-microbial nature yomhlaza, kuye kwaxelwa ukuba kuhambelana kakhulu neziphumo zeklinikhi, kodwa kusekho ukuqonda okulinganiselweyo malunga nendlela ukusebenzisana kwabo okuchaphazela ngayo iziphumo zesigulana. .
Ukwahlula ubudlelwane phakathi kobunzima be-phenotypic kunye nesiphumo, iqela labaphandi abavela kwiSidra Institute of Medical Research eQatar kutshanje liphuhlise kwaye liqinisekise inqaku elihlanganisiweyo (mICRoScore) elichonga iqela lezigulane ezinemilinganiselo emihle yokuphila ngokudibanisa iimpawu ze-microbiome kunye nokulahlwa komzimba. i-constants (ICR).Iqela lenze uhlalutyo olubanzi lwe-genomic yeesampulu ezintsha ezikhenkcezisiweyo ezivela kwizigulana ezingama-348 ezinomhlaza ophambili we-colorectal, kubandakanya ulandelelwano lwe-RNA yamathumba kunye nokudibanisa izicubu ezinempilo, ulandelelwano olupheleleyo lwe-exome, i-T-cell receptor enzulu kunye ne-16S yebhaktiriya ye-rRNA yolandelelwano yofuzo, eyongezwa lithumba elipheleleyo. ulandelelwano lwegenome ukubonakalisa ngakumbi i-microbiome.Uphononongo lwapapashwa kwiNature Medicine njenge "I-tumor edibeneyo, i-immune kunye ne-microbiome atlas ye-colon cancer".

Inqaku elipapashwe kwiNature Medicine

AC-ICAM Overview

Abaphandi basebenzise iqonga le-orthogonal genomic ukuhlalutya iisampulu zethumba enomkhenkce kwaye zihambelane nethishu yekholoni esempilweni (izibini ezihlala ziqhuma) kwizigulana ezinokuxilongwa komhlaza wekoloni ngaphandle konyango lwenkqubo.Ngokusekelwe kwi-whole-exome sequencing (WES), i-RNA-seq yokulawula umgangatho wedatha, kunye nokuhlolwa kweekhrayitheriya zokubandakanywa, idatha ye-genomic evela kwizigulane ze-348 zigcinwe kwaye zisetyenziselwa uhlalutyo olusezantsi kunye nokulandelwa okuphakathi kweminyaka eyi-4.6.Iqela lophando libize lo vimba we-Sidra-LUMC AC-ICAM: Imephu kunye nesikhokelo sokusebenzisana kwe-immune-cancer-microbiome (Umfanekiso 1).

Ukuhlelwa kweemolekyuli kusetyenziswa i-ICR

Ukubamba iseti yeemodyuli zeempawu zofuzo zokhuselo lomzimba oluqhubekayo lokugonywa komhlaza, okubizwa ngokuba yi-immune constant rejection (ICR), iqela lophando liye layenza ngcono i-ICR ngokuyidibanisa kwiphaneli yemfuza engama-20 egubungela iindidi ezahlukeneyo zomhlaza, kubandakanya imelanoma, umhlaza wesinyi, kunye umhlaza webele.I-ICR iye yadibaniswa nempendulo ye-immunotherapy kwiindidi ezahlukeneyo zomhlaza, kubandakanywa nomhlaza webele.

Okokuqala, abaphandi baqinisekisa ukutyikitywa kwe-ICR ye-AC-ICAM cohort, besebenzisa indlela ye-ICR esekelwe kwi-gene-based co-classification indlela yokuhlela iqela libe ngamaqela amathathu / i-immune subtypes: i-ICR ephezulu (i-tumor eshushu), i-ICR ephakathi kunye ne-ICR ephantsi (ibanda amathumba) (Umfanekiso 1b).Abaphandi babonakalisa ukuthambekela kwe-immune ehambelana ne-subtypes ye-molecular subtypes (CMS), ulwahlulo olusekwe kwi-transcriptome yomhlaza wekoloni.iindidi zeCMS zibandakanya iCMS1/immune, CMS2/canonical, CMS3/metabolic and CMS4/mesenchymal.Uhlalutyo lubonise ukuba amanqaku e-ICR anxulunyaniswa kakubi neendlela ezithile zeeseli zomhlaza kuzo zonke ii-subtypes ze-CMS, kwaye ulungelelwaniso olulungileyo kunye neendlela ezinxulumene ne-immunosuppressive kunye ne-stromal-zabonwa kuphela kwii-CMS4 tumors.

Kuzo zonke i-CMS, ubuninzi be-cell killer (NK) kunye ne-T cell subsets yayiphezulu kwi-ICR i-immune subtypes, kunye nokuhlukahluka okukhulu kwezinye iiseti ze-leukocyte (Umfanekiso 1c) . kwi-ICR ukusuka ezantsi ukuya phezulu (Figure 1d), eqinisekisa indima ye-ICR ye-prognostic kumhlaza we-colorectal.

Umzobo 1. Uyilo lokufunda lwe-AC-ICAM, isignesha ye-gene enxulumene nomzimba, i-immune kunye ne-molecular subtypes kunye nokusinda.
I-ICR ibamba i-tumor-eriched, i-clonal amplified T cells
Kuphela ligcuntswana iiseli T ukungena kwizicubu ithumba kuye kwaxelwa ukuba ngqo antigens ithumba (ngaphantsi kwe-10%).Ke ngoko, uninzi lweeseli ze-T ze-intra-tumor zibizwa ngokuba ziiseli T ezibukeleyo (iiseli T ezibukeleyo).Ukulungelelaniswa okunamandla kunye nenani leeseli ze-T eziqhelekileyo ezine-TCRs ezivelisayo zabonwa kwi-stromal cell kunye ne-leukocyte subpopulations (efunyenwe yi-RNA-seq), engasetyenziselwa ukuqikelela i-T cell subpopulations (Umfanekiso 2a).Kumaqela e-ICR (ngokubanzi kunye nokuhlelwa kwe-CMS), i-clonality ephezulu ye-immune SEQ TCRs yabonwa kwi-ICR-high kunye ne-CMS subtype CMS1 / amaqela omzimba omzimba (Umfanekiso 2c), kunye neyona ndawo iphezulu ye-ICR-high tumors.Ukusebenzisa i-transcriptome yonke (i-18,270 genes), i-ICR i-genenes ezintandathu (i-IFNG, i-STAT1, i-IRF1, i-CCL5, i-GZMA, kunye ne-CXCL10) yayiphakathi kweentlobo ezilishumi eziphezulu ezinxulumene ne-TCR immune SEQ clonality (Figure 2d).I-ImmunoSEQ TCR clonality idityaniswe ngamandla kuninzi lwe-ICR yofuzo kunolungelelwaniso olujongwe kusetyenziswa iziphawuli ze-CD8+ eziphendula ithumba (Umfanekiso 2f kunye ne-2g).Ukuqukumbela, olu hlalutyo lungentla lucebisa ukuba utyikityo lwe-ICR lubamba ubukho beeseli ze-T ezityebileyo, ezikhuliswe ngokudibeneyo kwaye zinokucacisa iziphumo zayo.

Umzobo 2. Iimethrikhi ze-TCR kunye nokulungelelaniswa kunye neegenes ezinxulumene ne-immune, i-immune kunye ne-molecular subtypes.
Ukubunjwa kwe-Microbiome kwizicubu zomhlaza we-colon onempilo
Abaphandi benza i-16S rRNA ngokulandelelana usebenzisa i-DNA ekhutshwe kwi-tumor ehambelanayo kunye ne-colon tissue enempilo evela kwizigulane ze-246 (Umfanekiso 3a).Ukuqinisekisa, abaphandi bahlalutya ngakumbi i-16S rRNA idatha yolandelelwano lwemfuza ukusuka kwisampulu eyongezelelweyo ye-42 ye-tumor engazange ihambelane ne-DNA eqhelekileyo ekhoyo ukuze ihlalutywe.Okokuqala, abaphandi bathelekisa ubuninzi bezityalo phakathi kwamathumba ahambelanayo kunye nezicubu zekholoni ezisempilweni.I-Clostridium perfringens yanda kakhulu kwii-tumors xa kuthelekiswa neesampuli eziphilileyo (Umfanekiso 3a-3d).Kwakungekho mahluko ubalulekileyo kwiiyantlukwano ze-alpha (ukwahlukana kunye nobuninzi beentlobo kwisampulu enye) phakathi kwe-tumor kunye neesampuli eziphilileyo, kunye nokunciphisa okuthobekileyo kwi-microbial diversity kwabonwa kwi-ICR-high tumors ngokumalunga ne-ICR-low tumors.
Ukubona unxulumano olufanelekileyo lweklinikhi phakathi kweeprofayili ze-microbial kunye neziphumo zeklinikhi, abaphandi bajonge ukusebenzisa i-16S rRNA idatha yokulandelelana kofuzo ukuchonga iimpawu ze-microbiome eziqikelela ukusinda.Kwi-AC-ICAM246, abaphandi baqhuba imodeli yokubuyisela i-OS Cox ekhethiweyo iimpawu ze-41 kunye ne-non-zero coefficients (ehambelana nomngcipheko wokufa okungafaniyo), ebizwa ngokuba yi-MBR classifiers (Figure 3f).
Kulo qela loqeqesho (i-ICAM246), inqaku eliphantsi le-MBR (MBR <0, i-MBR ephantsi) lidibene nomngcipheko ophantsi wokufa (85%).Abaphandi baqinisekisile umbutho phakathi kwe-MBR ephantsi (umngcipheko) kunye ne-OS ende kwii-cohorts ezimbini ezizimeleyo eziqinisekisiweyo (i-ICAM42 kunye ne-TCGA-COAD).(Umfanekiso 3) Uphononongo lubonise ukulungelelaniswa okuqinileyo phakathi kwe-cocci endogastric kunye namanqaku e-MBR, afana ne-tumor kunye ne-colon tissue enempilo.

Umzobo 3. I-Microbiome kwi-tumor kunye nezicubu ezinempilo kunye nobudlelwane kunye ne-ICR kunye nokusinda kwesigulane.
Ukuqukumbela
Indlela ye-multi-omics esetyenzisiweyo kolu phononongo yenza ukuba kubonwe ngokucokisekileyo kunye nohlalutyo lwesiginesha yemolekyuli yempendulo ye-immune kumhlaza we-colorectal kwaye ityhila intsebenziswano phakathi kwe-microbiome kunye ne-immune system.Ulandelelwano olunzulu lwe-TCR yethumba kunye nezihlunu ezisempilweni zibonise ukuba isiphumo se-ICR sinokubangelwa kukukwazi ukubamba i-tumor-etyetyiswe kwaye mhlawumbi i-tumor antigen-specific cell clones ye-T.

Ngokuhlalutya ukubunjwa kwe-tumor microbiome usebenzisa i-16S rRNA gene sequencing kwiisampuli ze-AC-ICAM, iqela lichonge isiginitsha ye-microbiome (inqaku lomngcipheko we-MBR) kunye nexabiso elinamandla le-prognostic.Nangona olu tyikityo luthatyathwe kwiisampulu zethumba, bekukho ulungelelwaniso olomeleleyo phakathi kwe-colorectum esempilweni kunye nenqanaba lomngcipheko we-tumor MBR, ecebisa ukuba olu tyikityo lunokuthi lubambe ukubunjwa kwe-gut microbiome yezigulana.Ngokudibanisa amanqaku e-ICR kunye ne-MBR, kwakunokwenzeka ukuchonga kunye nokuqinisekisa i-biomarker yomfundi we-multi-omic eqikelela ukusinda kwizigulane ezinomhlaza wekoloni.Iseti yedatha yophononongo ye-multi-omic ibonelela ngesixhobo sokuqonda ngcono ibhayoloji yomhlaza wekolon kunye nokunceda ukufumanisa iindlela zonyango zomntu.

Isalathiso:
Roelands, J., Kuppen, PJK, Ahmed, EI et al.I-tumor edibeneyo, i-immune kunye ne-microbiome atlas yomhlaza wekoloni.UNat Med 29, 1273-1286 (2023).